You have an LOI on the table, confirmatory diligence is compressed into a few weeks, and someone on the deal team just proposed spending six figures on a commercial due diligence consultant. Private equity buys measurable enterprise value, not analysis, so the real question is not whether the report will be thorough. It is whether the work will change what you decide: whether to proceed, at what price, with what conditions, and where the first hundred days of value creation should point. If you are an operating partner or a portfolio company executive holding the pen on that engagement, this guide is about how to scope it, who owns which decision, and how to judge the output before it becomes an expensive PDF nobody reads twice.
I will be direct about the failure mode. Most commercial due diligence gets bought as insurance and consumed as a formality. The deal closes, the report goes in a data room folder, and six months later the integration team rediscovers every risk the consultant already flagged, because nobody translated findings into an operating plan. That is a scoping failure, not a vendor failure. This piece is written to help you avoid it.
1. Start with the decision the work has to serve
Before you talk to a single firm, write down the decision. Not the deliverable, the decision. In buy-side commercial diligence there are usually only a handful that matter, and each one demands different evidence.
- Go or no-go. Is the commercial thesis real enough to proceed to close? This needs demand durability, competitive position, and customer concentration risk.
- Price and structure. Does the revenue base support the model, or should the offer come down, with an earnout absorbing the uncertainty? This needs revenue quality and forecast reliability.
- Conditions to close. What must be true, or fixed, before you sign? This needs a risk register with owners and severity.
- The value creation plan. Where does upside actually live, and how fast can it be captured? This needs a sized, sequenced set of commercial levers.
A commercial due diligence consultant in private equity who cannot tell you, in the kickoff call, which of these four their scope is built to answer is going to hand you a market study instead of a decision input. Bain’s annual Global Private Equity Report has tracked for years how much of returns now depend on operational improvement rather than multiple expansion, which is exactly why the value creation question can no longer be an afterthought bolted onto a market sizing exercise.
Write the four decisions on one page. Rank them for this deal. That ranking is the brief. Everything below flows from it.
2. Separate the commercial thesis from the market study
The single most common thing you will be sold is a market study dressed as a thesis test. A market study tells you the category is growing at some rate, names the competitors, and estimates a total addressable number. Useful context, but it does not tell you whether this company will keep winning in it.
The thesis test is different. It asks: why do these specific customers buy from this specific company, will they keep doing so after the deal, and what would break that. That is a question about retention curves, win and loss reasons, pricing power, and the health of the pipeline, not about a TAM chart.
What separates the two in the deliverable
- A market study leads with category CAGR. A thesis test leads with cohort retention and net revenue by cohort.
- A market study lists competitors. A thesis test explains where the target actually wins and loses head-to-head, with primary evidence.
- A market study estimates addressable revenue. A thesis test connects the pipeline to the forecast and tells you whether the plan is achievable with the current commercial engine.
Our own view on how to structure the buy-side version of this work is laid out in detail in the buy-side commercial due diligence guide. The short version: if the scope reads like a research report, you are paying premium diligence fees for a McKinsey-style landscape you could have commissioned in calmer times. McKinsey’s own private capital research is genuinely good at the macro picture, which is precisely why you should not pay a deal-timeline consultant to reproduce it.
3. Insist on primary evidence, not desk research assembled fast
Under time pressure, weak diligence defaults to desk research: analyst reports, the company’s own decks, and a few management interviews that mostly confirm the seller’s story. The tell is that everything in the report traces back to material the seller provided.
Primary evidence is the opposite. It comes from sources the seller does not control.
The primary sources that actually move a decision
- Customer reference calls, including calls with churned and lost accounts, not just happy references the CEO handpicked.
- Win/loss interviews with recent buyers and prospects who chose a competitor.
- Channel and partner conversations where the target’s go-to-market depends on third parties.
- Transaction-level data pulled and re-cut independently, not the summary tables in the CIM.
Ask any prospective firm how many primary interviews they will run, with whom, and how they will source churned customers. If the answer is vague, or if churned accounts are absent, the report will systematically overstate durability. That single gap has sunk more theses than any spreadsheet error.
4. Make the commercial and financial workstreams talk to each other
Commercial due diligence that runs in a sealed room from the quality of earnings work produces two reports that quietly contradict each other. The QoE says revenue is X. The commercial report assumes a growth rate that only holds if a chunk of that revenue is more durable than the QoE adjustments imply. You find the gap after close.
The fix is procedural. Require the commercial consultant to reconcile their revenue view against the QoE adjustments before the final read. This is where several problems surface that no one owns until it is too late. As we covered in the piece on the five data problems that survive a QoE, revenue recognition timing, customer identity across systems, and definitional drift in “active customer” all sit in the seam between the two workstreams. A good commercial consultant will ask for the QoE working file. A weak one will never mention it.
The AICPA’s guidance on quality of earnings work, available through AICPA and CIMA, is worth having your finance lead read alongside the commercial scope, so the two teams share a definition of what “revenue” even means before either starts.
5. Judge the go-to-market read specifically
The commercial thesis usually lives or dies on the go-to-market engine, and this is the part generalist diligence handles worst. A market can be attractive and the target can still be structurally unable to grow into it, because its sales motion, pricing, or channel economics are broken.
Questions a serious GTM read has to answer
- Is customer acquisition cost stable, rising, or masked by a few large deals that will not repeat?
- Does net revenue retention hold at the cohort level, or is gross churn being papered over by expansion in a handful of accounts?
- Is the pipeline coverage real, or is it inflated with stale opportunities that will never close?
- Does the sales team’s productivity scale, or does revenue depend on the founder personally closing?
We treat this as its own discipline for a reason. The full framework is in our guide to GTM due diligence in private equity. The point for you as the buyer of the engagement: if the commercial firm treats go-to-market as a subsection, you are underinvesting in the part of the diligence most likely to determine whether the plan hits. When the deal thesis rests on scaling the commercial engine, that read is not optional, it is the center of the work.
6. Require a value creation plan, not a risk list
A risk list tells you what could go wrong. A value creation plan tells you where enterprise value comes from and how you capture it. You are buying a private-equity operating asset, not a compliance document, so the commercial diligence should hand you the first draft of the plan you will execute after close.
That plan should size each lever, classify it honestly, and sequence it. Be strict about classification. A lever is either realized already, run-rate as of close, forecast under the plan, enabled by an investment you still have to make, or a risk you are avoiding. When a consultant presents forecast upside as if it were run-rate, the whole plan inflates. Ask them to label every lever with one of those five categories. The honest ones do it without prompting.
The levers a commercial read should size
- Pricing. Is there unrealized pricing power, and what evidence from win/loss and elasticity supports it?
- Retention. Where is churn recoverable, and what would it take?
- Sales productivity. Can the existing motion be tightened, or does it need rebuilding?
- Channel and segment mix. Are there underserved segments the current GTM ignores?
Our detailed take on translating diligence into an actual plan is in GTM value creation for portfolio companies. The link between diligence and the first 100 days is where most value leaks. If the commercial consultant’s work cannot be handed straight to the integration team as a starting operating plan, it was scoped as insurance, not as a value creation input.
7. Match the consultant to the deal, not to the brand
Brand-name firms deliver polished, defensible reports, and sometimes that defensibility is worth paying for, especially when the diligence has to satisfy an investment committee or lenders who want a recognizable logo on the cover. But the recognizable logo often means a leveraged team of junior analysts running the primary work, with the senior partner appearing at the read-out. For a lower-mid-market deal, a smaller specialist firm with sector depth and senior people doing the actual interviews frequently produces a sharper commercial read.
How to decide which you need
- Deal size and financing. Larger, lender-heavy deals often need brand-name defensibility. Smaller deals reward specialist depth.
- Sector complexity. Niche or technical markets favor a firm that already knows the buying behavior, over a generalist learning it on your timeline.
- Who does the work. Ask, in writing, who runs the customer interviews and who writes the findings. Names, not titles.
We wrote a fuller checklist on this in how to judge a commercial due diligence firm before you commit the budget. The trade publications are useful for reading which firms are active in your segment: Private Equity International, Buyouts, and PE Hub all cover advisory activity, and PitchBook data can tell you who has worked recently in your sector.
8. Do not let the commercial read ignore the technical and data reality
Plenty of commercial theses depend on things the commercial consultant is not equipped to assess. If the growth plan assumes the product platform can scale, or that the data can support the reporting the value creation plan needs, the commercial read has to flag those dependencies even if it cannot resolve them.
This is where commercial diligence and technology due diligence have to be coordinated rather than commissioned in isolation. If the plan hinges on shipping a new product to a new segment, someone needs to open the codebase, which is a different exercise entirely, as we covered in what a buyer’s team actually opens first in a source code review. A commercial consultant who says “the product roadmap supports the plan” without any technical input is guessing.
The same applies to CRM and reporting infrastructure. If the value creation plan depends on sales productivity gains, but the target’s systems cannot produce reliable pipeline data, the plan is built on sand. Our piece on CRM standardization across portfolio companies covers why this dependency surfaces again in every add-on. Flag it in diligence and it becomes a Day 1 workstream. Miss it and it becomes a Q3 surprise.
9. Scope, price, and timeline before you compare proposals
You cannot compare two proposals that are scoped differently, and firms know this. One proposal quotes a lower number because it excludes primary interviews. Another looks expensive but includes the churned-customer work that actually protects you. Normalize the scope yourself before you read the prices.
The scope elements to fix before you send the RFP
- Number and type of primary interviews, including a minimum for churned and lost accounts.
- Independent re-cut of transaction data versus reliance on seller summaries.
- Reconciliation against the QoE working file.
- A sized, classified value creation plan as a required deliverable, not an appendix.
- A named senior person doing the analysis, and a defined turnaround against your confirmatory diligence deadline.
Fix those five, then let firms bid against the same brief. On timeline, be realistic. Compressing serious primary research into a week produces the desk-research report you were trying to avoid. If the calendar between LOI and confirmatory diligence is genuinely short, cut scope deliberately by ranking the four decisions from section one, rather than letting the consultant quietly cut the primary work to hit the date.
10. Judge the output against what you can act on
When the draft arrives, resist grading it on polish. Grade it on whether it changes a decision. Run the deliverable through a short test.
The read-out test
- Does it answer the ranked decisions? Go over the four decisions from section one and check each is addressed with evidence, not adjacent to it.
- Is the evidence primary? Pick three key claims and trace them to source. If they all trace to seller material, the report is confirmation, not diligence.
- Is upside classified honestly? Check that forecast and enabled value are not dressed as run-rate.
- Can the integration team use it Monday? If the value creation section cannot be handed to whoever runs the first hundred days, it is incomplete.
- Are the risks owned? Every material risk should have a severity, an owner, and a condition to close or a mitigation.
Governance research collected by the Harvard Law School Forum on Corporate Governance and the M&A archive at Harvard Business Review both keep returning to the same lesson: deals fail in integration far more often than in the model, and the diligence that transfers cleanly into the operating plan is the diligence that pays for itself. Treat the read-out as the moment the report becomes an operating document, not the moment it gets filed.
11. Connect diligence to the operating cadence you will actually run
The best commercial diligence sets up the metrics you will track from Day 1. If the consultant identified pricing upside, the baseline for that lever should carry straight into your board reporting. If retention was the concern, the cohort definitions used in diligence should become the cohorts you monitor. Continuity of definition matters more than most buyers expect, because a metric that is measured one way in diligence and another way in the boardroom cannot tell you whether the plan is working.
This is also where operational discipline pays off after close. The habit of small, measured process improvement, the kind we described in the Kaizen guide for SME process savings, is what turns a diligence finding about sales productivity into a compounding gain rather than a slide. And where the plan depends on repositioning what the company sells, the disciplined approach in our value proposition budgeting guide keeps the commercial repositioning tied to a budget rather than a wish list.
The broader point is one the whole discipline of private equity value creation keeps proving: diligence and execution are not separate phases. The report is the first version of the operating plan. Scope it that way and it earns its fee. Scope it as insurance and you pay twice, once for the report and again for rediscovering everything it already told you.
12. A checklist for the buyer signing the engagement
Before you commit the budget, work through this. If more than a couple of items are soft, tighten the scope before you sign, not after.
- The four decisions the work must serve are written down and ranked for this deal.
- The scope tests the commercial thesis, not just the market size.
- Primary interviews are specified, with a minimum for churned and lost accounts.
- Transaction data will be re-cut independently, not taken from seller summaries.
- The commercial view will be reconciled against the QoE working file.
- The go-to-market engine gets a dedicated read, not a subsection.
- A sized, classified value creation plan is a required deliverable.
- Technical and data dependencies in the plan are flagged, with coordination to a technology read where needed.
- A named senior person does the analysis and interviews.
- The turnaround fits your confirmatory diligence deadline without gutting the primary work.
- The output will be judged on decisions changed, not on polish.
- Diligence metrics and cohort definitions carry into your Day 1 reporting.
For further reading on the people side of this, our guides on hiring a GTM strategy consultant for portfolio companies cover how the same rigor applies when you move from diligence to execution. Market context on where returns are being made is well tracked by BCG’s principal investors and private equity practice, S&P Global Market Intelligence, and the alternative-assets data at Preqin, and disclosure expectations for anything touching a regulated process sit with the U.S. Securities and Exchange Commission.
None of this is legal, tax, or valuation advice. It is how to scope, buy, and grade the commercial work so it changes the decision you are making rather than decorating it.
Ready to scope the commercial read that actually feeds your plan?
If you are heading into confirmatory diligence and want a commercial and GTM read built to hand straight to your first-hundred-days team, see how the DevriX private equity commercial and GTM diligence engagement is structured around the decisions above.